NCT05942469 Fostering Optimal Regulation of Emotion for Prevention of Secondary Trauma (FOREST)
| NCT ID | NCT05942469 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwestern University |
| Condition | Burnout |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-03-18 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-03-18 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
FOREST is a positive emotion skills program designed to target mental health and coping needs for frontline violence prevention workers at UCAN. Ten skills are taught over a period of nine months during existing meetings and wellness activities, as well as in online modules in UCAN's Learning Management System (LMS). Through infusing the FOREST skills throughout UCAN, we hope to inspire organizational culture change that will emphasize the importance of wellbeing and enhance resilience, therefore reducing burnout and turnover.
Eligibility Criteria
Inclusion Criteria: * Age 18 and over * Currently employed by UCAN * Has internet access * Speaks and reads English Exclusion Criteria: * None
Contact & Investigator
Judith Moskowitz, PhD, MPH
PRINCIPAL INVESTIGATOR
Northwestern University
Frequently Asked Questions
Who can join the NCT05942469 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Burnout. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05942469 currently recruiting?
Yes, NCT05942469 is actively recruiting participants. Contact the research team at amanda.summers@northwestern.edu for enrollment information.
Where is the NCT05942469 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT05942469 clinical trial?
NCT05942469 is sponsored by Northwestern University. The principal investigator is Judith Moskowitz, PhD, MPH at Northwestern University. The trial plans to enroll 100 participants.